<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-62826</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">B-cell pseudolymphoma caused by aluminium hydroxide following hyposensitization therapy</dc:title>
<dc:description xml:lang="en">Aluminium hydroxide is used as an adjuvant in vaccines. We describe the case of a patient who presented a persistent adverse local reaction to aluminium hydroxide due to hyposensitization therapy to dust mites. Multiple painful and pruriginous subcutaneous nodules were observed in both arms, along with hypertrichosis at the injection site. Histology revealed a pseudolymphomatous B cell reaction predominantly involving cells that were CD20 positive, did not express bcl-2, and did not display the t (14-18) translocation. The cells also exhibited polyclonal rearrangement of the immunoglobulin heavy chains. X-ray spectral microanalysis revealed deposits of inorganic aluminium in the granular histiocytes among the germinal centers. The patient was diagnosed with cutaneous B-cell pseudolymphoma due to aluminium hydroxide as a result of immunotherapy (AU)</dc:description>
<dc:creator>Alfaro, A</dc:creator>
<dc:creator>Cardá, C</dc:creator>
<dc:creator>Góme, S</dc:creator>
<dc:creator>Hernández, I</dc:creator>
<dc:creator>Sanmartín, O</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El hidróxido de aluminio es una sustancia que se utiliza como adyuvante de las vacunas. Describimos el caso de una paciente que presenta una reacción adversa local y persistente a esta sustancia debido al tratamiento hiposensibilizante frente a los ácaros. Clínicamente se observan múltiples nódulos subcutáneos en ambos brazos, dolorosos, pruriginosos y con hipertricosis en el sitio de la inyección. El estudio histológico muestra una reacción pseudolinfomatosa de tipo B con predominio de células CD20 positivas, bcl-2 y t (14-18) negativos y una policlonalidad de los genes de cadenas pesadas de las inmunoglobulinas. El microanálisis de espectro de rayos X identificó depósitos inorgánicos de aluminio dentro de los histiocitos granulares entre los centros germinativos. Se establece el diagnóstico de pseudolinfoma B cutáneo por hidróxido de aluminio secundario a una inmunoterapia (AU)</dc:description>
<dc:source>Actas Dermosifiliogr;99(3): 213-216, abr. 2008. ilus</dc:source>
<dc:identifier>ibc-62826</dc:identifier>
<dc:title xml:lang="es">Pseudolinfoma B inducido por hidróxido de aluminio tras tratamiento hiposensibilizante</dc:title>
<dc:subject>^d537^s22020</dc:subject>
<dc:subject>^d22921^s22045</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d23123^s22020</dc:subject>
<dc:subject>^d22205^s22002</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d22205^s22001</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d7345^s22045</dc:subject>
<dc:subject>^d30694^s22012</dc:subject>
<dc:subject>^d8398^s22036</dc:subject>
<dc:subject>^d7162^s22036</dc:subject>
<dc:subject>^d9157^s22045</dc:subject>
<dc:subject>^d8398^s22012</dc:subject>
<dc:subject>^d7162^s22012</dc:subject>
<dc:subject>^d9157^s22066</dc:subject>
<dc:subject>^d7345^s22020</dc:subject>
<dc:type>article</dc:type>
<dc:date>200804</dc:date>
</metadata>
</record>
</ibecs-document>
